 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
3 terms
|
 |
|
Biological process
|
negative regulation of growth of symbiont in host
|
51 terms
|
 |
|
Biochemical function
|
cytokine activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Protein Sci
5:1955-1962
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.
|
|
A.Zdanov,
C.Schalk-Hihi,
A.Wlodawer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of human interleukin-10 (IL-10) was refined at 1.6 A
resolution against X-ray diffraction data collected at 100 K with the use of
synchrotron radiation. Although similar to the IL-10 structure determined
previously at room temperature, this low-temperature IL-10 structure contains,
in addition, four N-terminal residues, three sulfate anions, and 175 extra water
molecules. Whereas the main-chain conformation is preserved, about 30% of the
side chains, most of them on the protein surface, assume different
conformations. A computer model of a complex of IL-10 with its two soluble
receptors was generated based on the topological similarity of IL-10 to
interferon-gamma. The contact region between the cytokine and each receptor
shows excellent complementarity of polar and hydrophobic interactions,
suggesting that the model is generally correct and should be useful in guiding
mutagenesis experiments.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Distribution of temperature factors (E) inboththe RT an
LT (red) structures of E-10.
|
 |
Figure 4.
Fig. 4. The 2F0 - F, electrondensitymapscorre-
pondingtothedifferentconformations of Leu-13
t RT (bluemap,greencoordinate)andat LT pink
map,redcoordinate).
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the Protein Society:
Protein Sci
(1996,
5,
1955-1962)
copyright 1996.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Akdis,
S.Burgler,
R.Crameri,
T.Eiwegger,
H.Fujita,
E.Gomez,
S.Klunker,
N.Meyer,
L.O'Mahony,
O.Palomares,
C.Rhyner,
N.Quaked,
A.Schaffartzik,
W.Van De Veen,
S.Zeller,
M.Zimmermann,
and
C.A.Akdis
(2011).
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.
|
| |
J Allergy Clin Immunol, 127,
701.
|
 |
|
|
|
|
 |
A.Zdanov
(2010).
Structural analysis of cytokines comprising the IL-10 family.
|
| |
Cytokine Growth Factor Rev, 21,
325-330.
|
 |
|
|
|
|
 |
D.B.Trivella,
J.R.Ferreira-Júnior,
L.Dumoutier,
J.C.Renauld,
and
I.Polikarpov
(2010).
Structure and function of interleukin-22 and other members of the interleukin-10 family.
|
| |
Cell Mol Life Sci, 67,
2909-2935.
|
 |
|
|
|
|
 |
H.H.Gad,
O.J.Hamming,
and
R.Hartmann
(2010).
The structure of human interferon lambda and what it has taught us.
|
| |
J Interferon Cytokine Res, 30,
565-571.
|
 |
|
|
|
|
 |
R.Sabat,
G.Grütz,
K.Warszawska,
S.Kirsch,
E.Witte,
K.Wolk,
and
J.Geginat
(2010).
Biology of interleukin-10.
|
| |
Cytokine Growth Factor Rev, 21,
331-344.
|
 |
|
|
|
|
 |
C.Jenkins,
W.Garcia,
M.J.Godwin,
J.V.Spencer,
J.L.Stern,
A.Abendroth,
and
B.Slobedman
(2008).
Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.
|
| |
J Virol, 82,
3736-3750.
|
 |
|
|
|
|
 |
M.de Oliveira Neto,
J.R.Ferreira,
D.Colau,
H.Fischer,
A.S.Nascimento,
A.F.Craievich,
L.Dumoutier,
J.C.Renauld,
and
I.Polikarpov
(2008).
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.
|
| |
Biophys J, 94,
1754-1765.
|
 |
|
|
|
|
 |
J.B.Mumm,
S.Ekmekcioglu,
N.J.Poindexter,
S.Chada,
and
E.A.Grimm
(2006).
Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes.
|
| |
J Interferon Cytokine Res, 26,
877-886.
|
 |
|
|
|
|
 |
S.R.McAllister,
B.E.Mickus,
J.L.Klepeis,
and
C.A.Floudas
(2006).
Novel approach for alpha-helical topology prediction in globular proteins: generation of interhelical restraints.
|
| |
Proteins, 65,
930-952.
|
 |
|
|
|
|
 |
S.Pletnev,
E.Magracheva,
A.Wlodawer,
and
A.Zdanov
(2005).
A model of the ternary complex of interleukin-10 with its soluble receptors.
|
| |
BMC Struct Biol, 5,
10.
|
 |
|
|
|
|
 |
H.Fickenscher,
S.Hör,
H.Küpers,
A.Knappe,
S.Wittmann,
and
H.Sticht
(2002).
The interleukin-10 family of cytokines.
|
| |
Trends Immunol, 23,
89-96.
|
 |
|
|
|
|
 |
K.Josephson,
B.C.Jones,
L.J.Walter,
R.DiGiacomo,
S.R.Indelicato,
and
M.R.Walter
(2002).
Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography.
|
| |
Structure, 10,
981-987.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.W.Moore,
R.de Waal Malefyt,
R.L.Coffman,
and
A.O'Garra
(2001).
Interleukin-10 and the interleukin-10 receptor.
|
| |
Annu Rev Immunol, 19,
683-765.
|
 |
|
|
|
|
 |
K.Asadullah,
W.D.Döcke,
R.V.Sabat,
H.D.Volk,
and
W.Sterry
(2000).
The treatment of psoriasis with IL-10: rationale and review of the first clinical trials.
|
| |
Expert Opin Investig Drugs, 9,
95.
|
 |
|
|
|
|
 |
S.V.Kotenko,
S.Saccani,
L.S.Izotova,
O.V.Mirochnitchenko,
and
S.Pestka
(2000).
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).
|
| |
Proc Natl Acad Sci U S A, 97,
1695-1700.
|
 |
|
|
|
|
 |
Y.Ding,
L.Qin,
S.V.Kotenko,
S.Pestka,
and
J.S.Bromberg
(2000).
A single amino acid determines the immunostimulatory activity of interleukin 10.
|
| |
J Exp Med, 191,
213-224.
|
 |
|
|
|
|
 |
D.M.Hoover,
C.Schalk-Hihi,
C.C.Chou,
S.Menon,
A.Wlodawer,
and
A.Zdanov
(1999).
Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization.
|
| |
Eur J Biochem, 262,
134-141.
|
 |
|
|
|
|
 |
J.Grötzinger,
T.Kernebeck,
K.J.Kallen,
and
S.Rose-John
(1999).
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
|
| |
Biol Chem, 380,
803-813.
|
 |
|
|
|
|
 |
K.E.Mogensen,
M.Lewerenz,
J.Reboul,
G.Lutfalla,
and
G.Uzé
(1999).
The type I interferon receptor: structure, function, and evolution of a family business.
|
| |
J Interferon Cytokine Res, 19,
1069-1098.
|
 |
|
|
|
|
 |
U.Reineke,
J.Schneider-Mergener,
R.W.Glaser,
R.D.Stigler,
M.Seifert,
H.D.Volk,
and
R.Sabat
(1999).
Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope.
|
| |
J Mol Recognit, 12,
242-248.
|
 |
|
|
|
|
 |
U.Reineke,
R.Sabat,
H.D.Volk,
and
J.Schneider-Mergener
(1998).
Mapping of the interleukin-10/interleukin-10 receptor combining site.
|
| |
Protein Sci, 7,
951-960.
|
 |
|
|
|
|
 |
B.Gesser,
H.Leffers,
T.Jinquan,
C.Vestergaard,
N.Kirstein,
S.Sindet-Pedersen,
S.L.Jensen,
K.Thestrup-Pedersen,
and
C.G.Larsen
(1997).
Identification of functional domains on human interleukin 10.
|
| |
Proc Natl Acad Sci U S A, 94,
14620-14625.
|
 |
|
|
|
|
 |
R.J.Simpson,
A.Hammacher,
D.K.Smith,
J.M.Matthews,
and
L.D.Ward
(1997).
Interleukin-6: structure-function relationships.
|
| |
Protein Sci, 6,
929-955.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|